跳至主要内容
临床试验/JPRN-UMIN000013932
JPRN-UMIN000013932招募中未知

Recurrent Embolism Lessened by Rivaroxaban, an Anti-Xa Agent of Early Dosing for Acute Ischemic Stroke and Transient Ischemic Attack With Atrial Fibrillation Study (RELAXED) - RELAXED: Recurrent Embolism Lessened by Rivaroxaban for Acute Ischemic Stroke

Japan Cardiovascular Research Foundation, and National Cerebral and Cardiovascular Center0 个研究点目标入组 2,000 人开始时间: 2014年5月12日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
2,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) hypersensitivity to rivaroxaban 2) Active bleeding (clinically significant hemorrhage) including gastrointestinal hemorrhage 3) liver disease complicated with coagulation disorder 4) liver disorder corresponding to Child-Pugh Class B or C 5) renal failure (creatinine clearance: <15 mL/minute) 6) poorly controlled hypertension (higher than 180/100) 7) Woman who are or are likely to be pregnant 8) Ongoing treatment with HIV protease inhibitors including ritonavir, atazanavir and indinavir 9) Ongoing treatment with itraconazole, voriconazole and ketoconazole 10) Active bacterial endocarditis 11) Patients considered by the investigator to be unsuitable for participating in this study

研究者

发起方
Japan Cardiovascular Research Foundation, and National Cerebral and Cardiovascular Center

相似试验